Browse everything: Tickers A–Z · Issuers · Comparisons · Tags
BDSX Stock — Biodesix Inc
Biodesix Inc (BDSX)
Updated October 16, 2026.
BDSX is a Stock. Total return is -90.8% over the past 6 years, 244.1 points behind SPY at 153.3%.
Biodesix operates as a diagnostic solutions company offering blood-based lung cancer tests, including its Nodify and IQLung testing platforms designed to assess lung nodule risk and guide treatment decisions, along with translational research and laboratory services for biopharmaceutical and life sciences clients. The company does not currently distribute to shareholders. Biodesix appeals primarily to investors seeking exposure to the diagnostics and healthcare sectors rather than those focused on dividend income.
BDSX performance versus SPY
Price and return data through 2026-10-16.
Total return is -90.8% over the past 6 years, 244.1 points behind SPY at 153.3%. Over the past year its total return — price change plus distributions reinvested — is 240.4%. Its deepest 1-year drawdown was 49.3%.
| Window | Total return | CAGR |
|---|---|---|
| 1M | -17.2% | — |
| 3M | 18.5% | — |
| 6M | 77.8% | — |
| YTD | 247.9% | — |
| 1Y | 240.4% | — |
| 2Y CAGR | — | -15.60% |
| 3Y CAGR | — | -10.50% |
| 5Y CAGR | — | -30.90% |
| Since inception (6 years) | -90.8% | -32.90% |
BDSX key facts
- Asset type
- Stock
- Asset class
- Equity
- Inception date
- 10/28/2020
- Distribution frequency
- None
- Last close
- $23.66 (as of 2026-10-16)
- Market cap
- $249,639,452
- Average volume
- 79571.0
- Beta
- 0.552
- Payout ratio
- 0.0%
- EPS
- $-3.10
How Dividend Vision calculates yield and returns
Distribution rate (the posted rate) uses calculation basis unavailable. Issuer rates can use a different denominator and date, including ex-date NAV. Trailing-12-month yield is the sum of split-adjusted cash distributions with ex-dates in the last 12 months, divided by the published price. It lags a recent raise or cut. Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.
Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology
Sources and review
Primary sources: prices and distributions from Dividend Vision, derived from vendor EOD data.
Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.
BDSX risks and drawbacks
Total return has trailed SPY over the available window. The deepest 1-year drawdown on record here is 49.3%.
Who may consider BDSX — and who may not
It is a weaker fit for investors who need monthly cash flow (BDSX does not currently distribute); investors whose main goal is matching SPY total return. This is educational context, not a recommendation to buy or sell.
More on BDSX
Frequently asked questions
Does BDSX pay monthly?
No. BDSX does not currently distribute.
When does BDSX pay a dividend?
BDSX does not currently distribute.
How has BDSX performed?
Total return is -90.8% over the past 6 years, 244.1 points behind SPY at 153.3%. Over the past year its total return — price change plus distributions reinvested — is 240.4%. Its deepest 1-year drawdown was 49.3%.
Tickers
Holdings as-of date unavailable.
| Ticker | Name | Weight |
|---|
See how this investment would fit into your portfolio.